OIG slaps PharMerica with $21.8 million kickback penalty

Check out important updates from the FDA for the week of April 15.

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.

Test your pharmacy news knowledge with our weekly quiz.

Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.

The antibiotic was approved to treat Staphylococcus aureas bacteremia, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.